Moderna to Present at Upcoming Conferences in September 2025
-
Man City players face Christmas weigh-in as Guardiola issues 'fatty' warning
-
German Christmas markets hit by flood of fake news
-
Liverpool fear Isak has broken leg: reports
-
West Indies captain says he 'let the team down' in New Zealand Tests
-
Thailand says Cambodia agrees to border talks after ASEAN meet
-
Alleged Bondi shooters conducted 'tactical' training in countryside, Australian police say
-
Swiss court to hear landmark climate case against cement giant
-
Knicks' Brunson scores 47, Bulls edge Hawks epic
-
Global nuclear arms control under pressure in 2026
-
Asian markets rally with Wall St as rate hopes rise, AI fears ease
-
Jailed Malaysian ex-PM Najib loses bid for house arrest
-
Banned film exposes Hong Kong's censorship trend, director says
-
Duffy, Patel force West Indies collapse as NZ close in on Test series win
-
Australian state pushes tough gun laws, 'terror symbols' ban after shooting
-
A night out on the town during Nigeria's 'Detty December'
-
US in 'pursuit' of third oil tanker in Caribbean: official
-
CO2 soon to be buried under North Sea oil platform
-
Steelers edge Lions as Bears, 49ers reach playoffs
-
India's Bollywood counts costs as star fees squeeze profits
-
McCullum admits errors in Ashes preparations as England look to salvage pride
-
Pets, pedis and peppermints: When the diva is a donkey
-
'A den of bandits': Rwanda closes thousands of evangelical churches
-
Southeast Asia bloc meets to press Thailand, Cambodia on truce
-
As US battles China on AI, some companies choose Chinese
-
AI resurrections of dead celebrities amuse and rankle
-
Heirs Energies Agrees $750m Afreximbank Financing to Drive Long-Term Growth
-
Black Book Poll: "Governed AI" Emerges as the Deciding Factor in 2026 NHS Procurement
-
Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares
-
Pantheon Resources PLC Announces Shareholder Letter and Corporate Update on Dubhe-1
-
Tocvan Begins Trenching Material for the Pilot Mine and Pushes Ahead With Infrastructure Development
-
Steelers receiver Metcalf strikes Lions fan
-
Morocco coach 'taking no risks' with Hakimi fitness
-
Gang members given hundreds-years-long sentences in El Salvador
-
Chargers, Bills edge closer to playoff berths
-
Gang members given hundred-years-long sentences in El Salvador
-
Hosts Morocco off to winning start at Africa Cup of Nations
-
No jacket required for Emery as Villa dream of title glory
-
Amorim fears United captain Fernandes will be out 'a while'
-
Nigerian government frees 130 kidnapped Catholic schoolchildren
-
Captain Kane helps undermanned Bayern go nine clear in Bundesliga
-
Captain Kane helps undermanned Bayern go nine clear
-
Rogers stars as Villa beat Man Utd to boost title bid
-
Barca strengthen Liga lead at Villarreal, Atletico go third
-
Third 'Avatar' film soars to top in N. American box office debut
-
Third day of Ukraine settlement talks to begin in Miami
-
Barcelona's Raphinha, Yamal strike in Villarreal win
-
Macron, on UAE visit, announces new French aircraft carrier
-
Barca's Raphinha, Yamal strike in Villarreal win
-
Gunmen kill 9, wound 10 in South Africa bar attack
-
Allegations of new cover-up over Epstein files
NYSE - LSE
Moderna to Present at Upcoming Conferences in September 2025
CAMBRIDGE, MA / ACCESS Newswire / August 21, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the following upcoming investor conferences:
Morgan Stanley's 23rd Annual Global Healthcare Conference, on Monday, September 8th at 10:00am ET
Bernstein Insights: Healthcare Leaders and Disruptors, on Thursday, September 25th at 10:30am ET
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Media Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
P.Costa--AMWN